<DOC>
	<DOC>NCT00746005</DOC>
	<brief_summary>To study the short term effects of a pharmacological dose of fish oil on cognitive performance and on cerebral blood flow. Furthermore, we want to investigate whether carriers of the APOEÎµ4 allele respond differently to fish oil treatment compared to non-carriers.</brief_summary>
	<brief_title>Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 Allele</brief_title>
	<detailed_description />
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Men and women Diagnosed as having amnestic MCI: based on specific memory disturbances (cutoff of 1 sd, single or multiple domain amnestic MCI, according to Busse A et al37) Presence of a principal caregiver willing to assist for a successful participation Informed consent signed Current or recent (&lt;4 weeks) use of fish oil supplements Consumption of fish more than 2 times/week Current use of dementia (Alzheimer) medication Current use of acenocoumarol or other antithrombotic drugs (because of the high dose of fish oil) Serious liver disease Use of more than 4 glasses of alcohol per day Unable to participate as judged by the responsible medical physician Allergy to fish(oil) Swallowing problems Participation in another clinical trial less than 2 months before the start of the trial or at the same time</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>mild cognitive impairment</keyword>
</DOC>